WATCH NOW > President Biden signs executive orders that aim to boost government purchases from U.S. manufacturers

Vikings CB Holton Hill suspended additional 4 games for violating NFL's substance abuse policy

This is a photo of Holton Hill of the Minnesota Vikings NFL football team. Photo: AP Photo
This is a photo of Holton Hill of the Minnesota Vikings NFL football team.

Updated: July 23, 2019 05:30 PM

The Minnesota Vikings will be without a contributor in their defensive secondary for even longer than anticipated during the 2019 regular season.

The NFL announced on Tuesday that cornerback Holton Hill has been suspended without pay for an additional four games for violating the league's policy and program on substances of abuse. He was previously suspended for the first four games for the league's policy on performance-enhancing substances. 

RELATED: Vikings' Holton Hill suspended for four games

Hill will be eligible to participate in all preseason practices and games. However, he will not be able to return to the team's active roster until Oct. 25, after week eight. 

The undrafted free agent out of the University of Texas appeared in 16 games with three starts, 36 tackles, an interception and seven passes defensed, according to a release. 

Related Stories

Connect with KSTP


Join the conversation on our social media platforms. Share your comments on our Facebook, Instagram, and Twitter pages.

Credits

Tommy Wiita

Updated: July 23, 2019 05:30 PM
Published: July 23, 2019 12:00 AM

Copyright 2019 - KSTP-TV, LLC A Hubbard Broadcasting Company

Top Stories

Gov. Walz speaks during a press conference on education reform on Jan. 25, 2021.

Walz announces sweeping education plan amid ongoing pandemic

Police ID victim of St. Paul hit-and-run; search for suspect continues

Police ID victim of St. Paul hit-and-run; search for suspect continues

A vial of the COVID-19 vaccine from Moderna sits on a table top to be used in vaccinating employees in the first round of staff vaccinations at Rose Medical Center Wednesday, Dec. 23, 2020, in Denver.

Amid high demand, officials announce updates to Minnesota's community vaccination efforts

3 new COVID-related deaths, 794 new cases reported by MDH

3 new COVID-related deaths, 794 new cases reported by MDH

Remy, a blue merle border collie who was stolen along with a running car Saturday outside a Bloomington hotel.

UPDATE: Dog found after being taken in stolen vehicle outside Bloomington hotel; search for vehicle continues

Cars line up for COVID-19 testing, Tuesday, Jan. 5, 2021, outside Hard Rock Stadium in Miami Gardens, Fla. Coronavirus deaths and cases per day in the U.S. dropped markedly over the past couple of weeks but are still running at alarmingly high levels, and the effort to snuff out COVID-19 is becoming an ever more urgent race between the vaccine and the mutating virus.

US virus numbers drop, but race against new strains heats up

Most Read Stories

LIVE VIDEO: Walz announces sweeping education plan amid ongoing pandemic
Gov. Walz speaks during a press conference on education reform on Jan. 25, 2021.
21-year-old daughter of Allina Health CEO and Minnesota Supreme Court Justice found dead
Olivia Chutich
Distance learning lessons: Looking beyond the letter grade
Distance learning lessons: Looking beyond the letter grade
Budweiser joins Coke, Pepsi brands in sitting out Super Bowl
This image provided by Budweiser shows two health care workers getting vaccinated in an advertisement Budweiser is running before the Super Bowl. For the first time since 1983, when Anheuser-Busch used all of its ad time to introduce a beer called Bud Light, the beer giant isn't advertising its iconic Budweiser brand during the Super Bowl. Instead, it’s donating the money it would have spent on the ad to coronavirus vaccination awareness efforts.
Merck ends development of two potential COVID-19 vaccines
FILE- This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. The drugmaker will stop developing two potential COVID-19 vaccines after seeing poor results in early-stage studies. The company said Monday, Jan. 25, 2021, that it will focus instead on studying two possible treatments for the virus that also have yet to be approved by regulators.